Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Terminated
2(33%)

Phase Distribution

Ph phase_3
1
17%
Ph phase_4
5
83%

Phase Distribution

0

Early Stage

0

Mid Stage

6

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
5(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(3)
Terminated(2)
Other(1)

Detailed Status

Completed3
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
60.0%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (16.7%)
Phase 45 (83.3%)

Trials by Status

completed350%
unknown117%
terminated233%

Recent Activity

0 active trials
Showing 5 of 6
terminatedphase_4

Sugammadex vs Neostigmine Reversal in Pediatric Appendectomy

NCT05256901
completedphase_4

Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients

NCT06228092
completedphase_3

Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant

NCT03116997
completedphase_4

Comparison of Time to Extubation Using Sugammadex or Neostigmine

NCT04606901
terminatedphase_4

Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine

NCT02825576
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT05256901Phase 4

Sugammadex vs Neostigmine Reversal in Pediatric Appendectomy

Terminated
NCT06228092Phase 4

Neostigmine/Glyco-pyrrolate 50 Mikrogram/kg or Sugammadex 2 mg/kg for Reversal of Neuromuscular Blockade in Elderly Patients

Completed
NCT03116997Phase 3

Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant

Completed
NCT04606901Phase 4

Comparison of Time to Extubation Using Sugammadex or Neostigmine

Completed
NCT02825576Phase 4

Prevention of Postoperative Events Following Reversal With Sugammadex or Neostigmine

Terminated
NCT01453530Phase 4

Street Fitness in Surgical Patients Undergoing General Anesthesia After Reversal of Neuromuscular Blockade

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6